Clinical trial
Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With…
NCT00275912 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00275912 |
|---|---|
| Title | Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures |
| Official title | A 24-week Prospective Open-label Multicenter Study to Evaluate the Effect on Seizure Frequency, Safety and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Epilepsy, Partial Seizures |
| Intervention type | Drug |
| Interventions | Oxcarbazepine |
| Enrollment | 60 |
| Start date | Sep 11, 2006 |
| Primary completion | Sep 28, 2007 |
| Completion | Sep 28, 2007 |
| First posted | Jan 12, 2006 |
| Last update posted | Feb 23, 2017 |
| Countries | Russia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: